✦ LIBER ✦

Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib

✍ Scribed by Deininger, M. W. N.

Book ID: 126681943
Publisher: American Society for Pharmacology and Experimental Therapeutics
Year: 2003
Tongue: English
Weight: 622 KB
Volume: 55
Category: Article
ISSN: 0031-6997
DOI: 10.1124/pr.55.3.4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New Targeted Therapies for Chronic Myelo

New Targeted Therapies for Chronic Myelogenous Leukemia: Opportunities to Overcome Imatinib Resistance

✍ Elias Jabbour; Jorge Cortes; Susan O’Brien; Francis Giles; Hagop Kantarjian 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Cardiac tamponade associated with imatin

Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia

✍ James C. Barton; Steven C. Jones; Wade C. Lamberth; Michael T. Reymann; Varian C 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 2 views

Targeting lysosomes to eradicate imatini

Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells

✍ Puissant, A; Dufies, M; Raynaud, S; Cassuto, J-P; Auberger, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 287 KB

The Biology of Chronic Myelogenous Leuke

The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy

✍ Ricardo H. Alvarez; Hagop Kantarjian; Jorge E. Cortes 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 902 KB

Resistance to Targeted Therapy in Chroni

Resistance to Targeted Therapy in Chronic Myelogenous Leukemia

✍ Andreas Hochhaus; Philipp Erben; Thomas Ernst; Martin C. Mueller 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Management of Molecular-Targeted Therapy

Management of Molecular-Targeted Therapy for Chronic Myelogenous Leukemia

✍ Patricia Ault; Suzan Kaled; Mary Beth Rios 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB